EILEEN WIDRICK: Open Payments
NPI 1083800874 · CORPUS CHRISTI, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,413 in 51 payments from 14 companies in 2025. Trend: 2023 $1,452 · 2024 $2,166 · 2025 $1,413
Food & beverage: $1,413
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $479 |
| Novo Nordisk Inc | 15 | $359 |
| Dexcom, Inc. | 1 | $134 |
| GlaxoSmithKline, LLC. | 4 | $82 |
| AstraZeneca Pharmaceuticals LP | 4 | $74 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $53 |
| ABBVIE INC. | 2 | $44 |
| Phathom Pharmaceuticals, Inc. | 2 | $36 |
| CSL Behring | 1 | $24 |
Products named: Ozempic, ZEPBOUND, KISUNLA, DEXCOM G7 GSS (161), Wegovy, TRELEGY ELLIPTA, JARDIANCE, TRINTELLIX.
Industry payments across TX — which companies pay providers there.
